Efficacy and Safety of Guselkumab, an Anti–interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis

  • A Randomized Clinical Trial
  • Tadashi Terui, Satomi Kobayashi, Yukari Okubo, Masamoto Murakami, Keiichiro Hirose, Hiroshi Kubo
  • JAMA Dermatology, March 2018, American Medical Association (AMA)
  • DOI: 10.1001/jamadermatol.2017.5937

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1001/jamadermatol.2017.5937

The following have contributed to this page: Dr Hiroshi Kubo